Business Context and Reporting Period
Company: Alight, Inc. (NYSE: ALIT)
Filing Type: Form 10-K (Annual Report)
Reporting Period: Fiscal year ended December 31, 2024
Business Overview: Alight is a technology-enabled services company delivering human capital management solutions, primarily through its "Employer Solutions" segment. The company focuses on employee benefits administration, healthcare navigation, financial wellbeing, and leave management via its cloud-based Alight Worklife platform.
Material Event: On July 12, 2024, Alight completed the divestiture of its Professional Services segment and Payroll & HCM Outsourcing business (the "Divested Business") for total consideration of up to $1.2 billion. Results from these businesses are reported as discontinued operations.
Key Financial Metrics
| Metric (in millions) | 2024 | 2023 | Change |
|---|---|---|---|
| Revenue | $2,332 | $2,386 | (2.3%) |
| Gross Profit | $794 | $810 | (2.0%) |
| Operating Income (Loss) | $(90) | $(81) | Worsened |
| Net Income (Loss) Attributable to Alight | $(157) | $(345) | Improved |
| Adjusted EBITDA | $556 | $537 | 3.5% |
| Adjusted EBITDA Margin | 23.8% | 22.5% | +130 bps |
| Cash from Operating Activities | $193 | $247 | (21.9%) |
| Total Debt (Net) | $2,025 | $2,794 | (27.5%) |
| Cash and Cash Equivalents | $343 | $324 | 5.9% |
Material Changes vs. Prior Period
- Revenue Decline: Total revenue decreased by $54 million (2.3%) primarily due to lower volumes, net commercial activity, and the wind-down of hosted business operations. However, BPaaS (Business Process as a Service) revenue grew 15.0% to $499 million.
- Profitability Improvement: While GAAP Net Loss narrowed significantly from $(345) million to $(157) million, this was largely driven by non-operating items. Adjusted EBITDA increased to $556 million, reflecting improved operational efficiency and margin expansion.
- Divestiture Impact: The sale of the Divested Business generated $1.0 billion in cash proceeds. This transaction resulted in a $10 million loss on disposal (net of tax) recorded in discontinued operations.
- Debt Reduction: The company reduced total debt by approximately $769 million, utilizing proceeds from the divestiture to repay $440 million of term loans and fully retire $300 million in Secured Senior Notes.
- Shareholder Returns: The company initiated a quarterly dividend program ($0.04 per share) and repurchased 22.3 million shares of Class A Common Stock for approximately $167 million during the year.
Guidance, Outlook, and Risks
Management Commentary: Management views the divestiture as a pivotal step in transforming Alight into a focused technology-enabled services company. The company emphasizes the growth of its cloud-based Alight Worklife platform and AI-driven capabilities. Liquidity is described as strong, with sufficient resources to meet obligations, including the Tax Receivable Agreement (TRA).
Outlook:
- Capital Allocation: The Board authorized an additional $200 million share repurchase program in February 2025, bringing total remaining authorization to $281 million.
- Dividends: The company intends to continue paying regular quarterly cash dividends.
- Debt Refinancing: In January 2025, the company repriced its term loans, reducing the interest rate margin from SOFR + 2.25% to SOFR + 1.75%.
Key Risks and Contingencies:
- Tax Receivable Agreement (TRA): The company has a liability of $857 million (as of Dec 31, 2024) related to the TRA. Payments are expected to be substantial, with approximately $100 million due in 2025 and $175-$200 million in 2026.
- Goodwill Impairment: The Health Solutions reporting unit has a goodwill balance of $3,084 million. Management noted that a hypothetical 25-basis point increase in the discount rate could result in a $125 million impairment charge.
- Cybersecurity: As a data-intensive business, Alight faces risks from cyber-attacks and data breaches, which could lead to legal liability and reputational damage.
- Strategic Transformation: Risks associated with the successful separation of the Divested Business and the execution of the go-forward strategy remain material.
Investor Verification Checklist
- Divestiture Proceeds: Verify the final settlement of the $1.2 billion divestiture consideration, specifically the contingent note performance metrics for 2025.
- TRA Liability: Monitor the $857 million Tax Receivable Agreement liability and the company's ability to fund the projected $100 million+ payments in 2025 without impacting liquidity.
- Goodwill Sensitivity: Review the sensitivity of the Health Solutions goodwill valuation to changes in discount rates and growth assumptions, given the narrow margin of safety (1.2% excess fair value).
- BPaaS Growth: Track the 15% growth in BPaaS revenue to ensure the strategic pivot to cloud-based solutions is sustaining momentum despite overall revenue decline.
- Debt Covenants: Confirm compliance with debt covenants following the significant debt reduction and refinancing activities in late 2024 and early 2025.